Table Legend -
Table 1 – Control animals (aCSF) and treated with an NMDA receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor antagonist (NBQX - 1nmol/100nL). Result of the test of difference of means (student t test) of baseline values of MAP, HR and TST, before and after drug injection. Values expressed as mean ±SEM.
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX - 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; LY235959 - [3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid); MAP - mean blood pressure; HR - heart rate; TST – tail skin temperature; bpm - beats per minute; mmHg - millimeters of mercury; ºC - degree Celsius.
Table 2 – Control animals (aCSF) and treated with an NMDA receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor antagonist (NBQX - 1nmol/100nL). Result of the test of difference of means (student t test) of baseline values in the sequences of BEI (Up), BEI (Down) and BEI (All), before and after drug injection. Values expressed as mean ±SEM.
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX - 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; LY235959 - [3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid); BEI - baroreflex effectiveness index
Table 3 - Control animals (aCSF) and treated with an NMDA receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor antagonist (NBQX - 1nmol/100nL). Result of the test of difference of means (student t test) of baseline values in the sequences of Gain (Up), Gain (Down) and Gain (All), before and after drug injection. Values expressed as mean ± SEM
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX - 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; LY235959 - [3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid);